Skip to main content
Premium Trial:

Request an Annual Quote

What’s in a Name?

Premium

It’s true. PE is changing its name. The parent company of Celera Genomics and Applied Biosystems has been in dire need of a better handle ever since EG&G bought the right to spell-out Perkin-Elmer. In 1999, EG&G became Perkin-Elmer, and Perkin-Elmer was relegated to its own acronym. The confusion has been too much for customers to bear. (It’s still not uncommon to hear a technician refer to his “Perkin-Elmer 3700.”)

In October, stockholders approved the inspired new moniker: “Applera.”

Assuming that the naming effort has drained PE execs of whatever creative energy they had, we offer help on logos.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.